Back to Search
Start Over
Novel insights into macrophage immunometabolism in nonalcoholic steatohepatitis.
- Source :
-
International Immunopharmacology . Apr2024, Vol. 131, pN.PAG-N.PAG. 1p. - Publication Year :
- 2024
-
Abstract
- • This manuscript summarizes the role of macrophage immunometabolism in NASH, especially the function conversion. • The progress of regulatory factors of macrophage immunometabolism in NASH has been updated. Targeting macrophage immunometabolism become a potential strategy for treating NASH. Nonalcoholic steatohepatitis (NASH), an inflammatory subtype of nonalcoholic fatty liver disease (NAFLD), is characterized by liver steatosis, inflammation, hepatocellular injury and different degrees of fibrosis, and has been becoming the leading cause of liver-related morbidity and mortality worldwide. Unfortunately, the pathogenesis of NASH has not been completely clarified, and there are no approved therapeutic drugs. Recent accumulated evidences have revealed the involvement of macrophage in the regulation of host liver steatosis, inflammation and fibrosis, and different phenotypes of macrophages have different metabolic characteristics. Therefore, targeted regulation of macrophage immunometabolism may contribute to the treatment and prognosis of NASH. In this review, we summarized the current evidences of the role of macrophage immunometabolism in NASH, especially focused on the related function conversion, as well as the strategies to promote its polarization balance in the liver, and hold promise for macrophage immunometabolism-targeted therapies in the treatment of NASH. [ABSTRACT FROM AUTHOR]
- Subjects :
- *NON-alcoholic fatty liver disease
*MACROPHAGES
Subjects
Details
- Language :
- English
- ISSN :
- 15675769
- Volume :
- 131
- Database :
- Academic Search Index
- Journal :
- International Immunopharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 176432727
- Full Text :
- https://doi.org/10.1016/j.intimp.2024.111833